U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07624357) titled 'Bioequivalence Study of Vortioxetine in 20 mg Coated Tablets in Healthy Subjects Under Fasting Conditions' on May 21.
Brief Summary: Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study
Study Start Date: March 18, 2025
Study Type: INTERVENTIONAL
Condition:
Bioequivalance
Intervention:
DRUG: Reference
Trintellix 20 mg coated tablet
DRUG: Test
Vortioxetine 20 mg coated tablet
Recruitment Status: COMPLETED
Sponsor: ADIUM
Published by HT Digital Content Services with permission from Health Daily Digest....